title: Referral pattern for neoadjuvant chemotherapy in the head and neck cancers in a tertiary care center.
abstract: BACKGROUND
  Use of any treatment modality in cancer depends not only on the effectiveness of the modality, but also on other factors such as local expertise, tolerance of the modality, cost and prevalence of the disease. Oropharyngeal and laryngeal cancer are the major subsites in which majority of neoadjuvant chemotherapy (NACT) literature in the head and neck cancers is available. However, oral cancers form a major subsite in India.
  
  
  METHODS
  This is an analysis of a prospectively maintained data on NACT in the head and neck cancers from 2008 to 2012. All these patients were referred for NACT for various indications from a multidisciplinary clinic. Descriptive analysis of indications for NACT in this data base is presented.
  
  
  RESULTS
  A total of 862 patients received NACT within the stipulated time period. The sites where oral cavity 721 patients (83.6%), maxilla 41 patients (4.8%), larynx 33 patients (3.8%), laryngopharynx 8 patients (0.9%) and hypopharynx 59 patients (8.2%). Out of oral cancers, the major indication for NACT was to make the cancer resectable in all (100%) patients. The indication in carcinoma of maxilla was to make the disease resectable in 29 patients (70.7% of maxillary cancers) and in 12 patients (29.3% of maxillary cancers) it was given as an attempt to preserve the eyeball. The indication for NACT in laryngeal cancers was organ preservation in 14 patients (42.4% of larnyngeal cancer) and to achieve resectability in 19 patients (57.6% of larnyngeal cancer). The group with laryngopharynx is a cohort of eight patients in whom NACT was given to prevent tracheostomy, these patients had presented with early stridor (common terminology criteria for adverse events Version 4.02). The reason for NACT in hypopharyngeal cancers was for organ preservation in 24 patients (40.7% of hypopharyngeal cancer) and for achievement of resectability in 35 patients (59.3% of hypopharyngeal cancer).
  
  
  CONCLUSIONS
  The major indication for NACT is to make disease resectable at our center while cases for organ preservation are few.
authors.forename: V M
authors.initials: VM
authors.lastname: Patil
authors.forename: V
authors.initials: V
authors.lastname: Noronha
authors.forename: A
authors.initials: A
authors.lastname: Joshi
authors.forename: V M
authors.initials: VM
authors.lastname: Krishna
authors.forename: S
authors.initials: S
authors.lastname: Dhumal
authors.forename: V
authors.initials: V
authors.lastname: Chaudhary
authors.forename: S
authors.initials: S
authors.lastname: Juvekar
authors.forename: P S
authors.initials: PS
authors.lastname: Pai
authors.forename: C
authors.initials: C
authors.lastname: Pankaj
authors.forename: D
authors.initials: D
authors.lastname: Chaukar
authors.forename: A K
authors.initials: AK
authors.lastname: Dcruz
authors.affiliation: Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
authors.forename: K
authors.initials: K
authors.lastname: Prabhash
mesh_terms: D017024:Chemotherapy, Adjuvant; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D020360:Neoadjuvant Therapy; D010818:Practice Patterns, Physicians'; D012017:Referral and Consultation; D012189:Retrospective Studies; D062606:Tertiary Care Centers